**Core tip:** Multiple endocrine neoplasia (MEN) 2B is a rare anomaly caused by an activating mutation of the RET known to produce enteric gangliomatosis. Thyroidectomy is performed to avoid cancer and the colon removed to overcome the constipation. This child presented with constipation very early (1-mo-old) and had subtotal colectomy at 4 years. The classes of nerves affected in MEN2B colon have not been studied before. We used immunohistochemistry with multiple antibodies. There was a massive increase in intrinsic nerve fibres in myenteric and submucosal ganglia, with a differential increase in types of nerve fibres in the muscle and mucosa.

INTRODUCTION
============

Multiple endocrine neoplasia (MEN) 2B is a rare autosomal dominant anomaly characterised by marfanoid appearance, ganglioneuromatosis and gastrointestinal disorders\[[@B1]-[@B4]\]. There is a very high risk of medullary carcinoma of the thyroid (MTC) which increases with age, and a moderate risk of developing phaeochromocytoma\[[@B3]\]. MTC develops in infancy and originally determined the prognosis for MEN2B patients. In the last 15 years, it has been recognised that MTC is curable by surgical removal of the thyroid under 1-year-old\[[@B4]\].

The genetic anomaly in *MEN2B* is an activating mutation of *RET*\[[@B5]-[@B7]\], mostly M918T\[[@B5],[@B8]\]. The *RET* gene codes for a membrane-bound tyrosine kinase receptor that is activated by glial-derived neurotrophic factor (GDNF), that regulates growth and development of the peripheral, autonomic and enteric nervous systems\[[@B9]-[@B11]\]. In MEN2B, activation of RET results in hyperganglionosis in the nervous system including the enteric nervous system\[[@B1],[@B12],[@B13]\].

Constipation is present in many MEN2B patients\[[@B1],[@B2],[@B7],[@B12],[@B14]-[@B16]\], and they may present in the neonatal period with symptoms suspiciously like Hirschsprung disease (HSCR)\[[@B2],[@B16]-[@B20]\]. Indeed, MEN2B can be diagnosed in the neonatal period, by the presence of neurons among the enlarged nerves in submucosal ganglia in standard rectal biopsies\[[@B16],[@B18],[@B21]\]. Intestinal ganlioneuromatosis develops in an age-dependent fashion and not all develop severe constipation necessitating surgery. Removal of the thyroid does not alter the effect that RET activation has on the nervous system. We could not find any reports of the changes in the enteric nervous system post thyroidectomy. Also, despite numerous reports of hyperganglionosis, there are only a few histological images of the MEN2B intestine\[[@B12],[@B15],[@B16],[@B19]\]. Most of the images are haematoxylin and eosin and while they clearly show enlarged ganglia, they do not reveal the nerve fibres or how neuronal subtypes are affected in MEN2B. Here we examined the enteric nervous system in bowel from a child with severe constipation from birth, who had a colectomy at 4 years.

Choline acetyl transferase (ChAT) and nitric oxide synthase (NOS) are present in 95% of myenteric neurons (ChAT^+^/NOS^-^ 48%, ChAT^-^/NOS^+^ 43%, ChAT^+^/NOS^+^ 4%, ChAT^-^/NOS^-^ 5%)\[[@B22],[@B23]\]. Vasoactive intestinal peptide (VIP) is present in inhibitory motor and secretomotor neurons and substance P (SP) is in sensory, excitatory motor neurons and secretomotor neurons in the myenteric and submucosal ganglia\[[@B23],[@B24]\]. In this study we examined enteric nerves in samples taken from a child 3.5 years after thyroidectomy. We labelled full thickness bowel with antibodies against all these different molecules to determine if all of the neuron types were increased. We compared the labelling in the MEN2B case to 2 controls: Bowel from a patient with familial adenomatous polyposis (FAP) and the normal margin of bowel in a patient operated for HSCR. To determine if changes were specific to nerves, we also labelled the interstitial cells of Cajal (ICC), cells that have a different developmental origin to neurons (they arise from the mesenchyme)\[[@B25]\].

CASE REPORT
===========

This child (now 14 years) presented with chronic constipation at 1 mo (in 2003) and was investigated for HSCR with a rectal biopsy at 4 mo. A preliminary diagnosis of MEN2B was made from the mucosal biopsy stained for acetylcholinesterase and showing thickened nerve fibres with nerve cells present in the submucosal ganglia and we reported on this analysis in 2006\[[@B18]\]. Genetic analysis confirmed the *RET M918T* mutation and diagnosis of MEN2B and thyroidectomy was performed at 9 mo. At 4-year-old, the boy underwent subtotal colectomy for management of severe constipation. Terminal ileum and transverse colon were fixed and frozen. Blocks were sectioned (5 μm) and sections were processed for fluorescence immunohistochemistry\[[@B26],[@B27]\] using a bank of antibodies to label nerve cells and fibres, different subtypes of neurons and ICC. Antibodies were chosen to label all nerve fibres (Tuj1), nerve cell bodies (Hu), the major excitatory (ChAT and SP) and inhibitory (NOS and VIP) neurons and nerve fibres and extrinsic sensory nerve fibres (CGRP) in the myenteric plexus and muscle layers, and the major secretomotor nerves (SP and VIP) in the muscosa.

Cryostat sections (10 μm thick) were air-dried at 4 °C overnight and then incubated overnight at room temperature with primary antibody (Table [1](#T1){ref-type="table"}) followed by 2 h in secondary antibody (Table [1](#T1){ref-type="table"}), rinsed and mounted in (Mowiol 4-88 (Hoechst/Aventis) in 25% glycerol/0.1 mol/L Tris HCl, with 2.5% DABCO (1,4-diazabicyclo-\[2,2,2\]-octane, Sigma). Negative controls excluded primary and secondary antibodies. Staining was covered by Royal Children's Hospital Ethics Committee approval 23081B and 24105.

###### 

Antibodies used in the study

  **Molecule**                   **Company**                                                              **Dilution**
  ------------------------------ ------------------------------------------------------------------------ --------------
  Primary antibody                                                                                        
  Goat anti c ChAT               AB5966 Chemicon International, Temecula, CA, United States               1:100
  Rabbit anti nNOS               AB 5380, Chemicon International, Temecula, CA, United States             1:1000
  Rabbit anti VIP                NCL VIPp, Novocastra Laboratories, Newcastle-upon-Tyne, United Kingdom   1:200
  Rabbit anti SP                 18-0091, Zymed Laboratories, South San Francisco, CA, United States      1:50
  Goat anti CGRP                 1720-9-7, AbD Serotec, Biorad                                            1:1000
  Rabbit anti-human cKit         Polyclonal CD117, Dako                                                   1:200
  Secondary antibody                                                                                      
  Goat anti rabbit Alexa 488     Molecular Probes, ThermoFisher Scientific A-11012                        1:400
  Donkey anti rabbit Alexa 488   Molecular Probes, ThermoFisher Scientific, A-21206                       1:200
  Goat anti mouse Alexa 488      Molecular Probes, ThermoFisher Scientific, A11001                        1:400
  Donkey anti goat Alexa 568     Molecular Probes, ThermoFisher Scientific, A11057                        1:400

Sections were imaged on a Leica CSLM confocal microscope using 488 nm excitation with variable filters. For each antibody, the entire thickness of the colon wall was imaged to locate nerve fibres in the longitudinal and circular muscle, myenteric and submucosal ganglia, submucosa and mucosa (Figure [1](#F1){ref-type="fig"}). Quantitation was performed using NIH Image J. The thickness of the ganglia and muscle layers was measured in 24 sections from MEN2B patient and 15 sections from the controls. The density of nerve fibres labelled with each marker was measured in circular muscle cut in transverse section as previously described\[[@B26],[@B27]\] in 3 sections for each antibody.

![Nerve fibres in normal colon and MEN2B colon. Tuj1 immunoreactivity showing nerve fibres in full thickness biopsy of the transverse colon cut with circular muscle in cross section. A: Control patient (4-year-old, HSCR normal margin) showing multiple nerve fibres in the mucosa (Muc) within and at the base of the crypts, small ganglia in the submucosa (SM), nerve fibres in cross section in the circular muscle (CM) and myenteric ganglia (MG) between the CM and longitudinal muscle layer (LM); B: MEN2B patient showing greatly increased amount of labelling and increase in size of MG and SM ganglia. The MG is increased in diameter to a thickness similar to the circular muscle. The density and number of nerve fibres in the CM is higher than control. The nerve fibres in the Muc are greatly increased. The SM contains many large ganglia near the CM, near the Muc and in between. Neurons are not distinguishable because this antibody only displays nerve fibres. Note A and B are at the same magnification. CM: Circular mucle; LM: Longitudinal muscle; MG: Myenteric ganglia.](WJGP-8-142-g001){#F1}

Normal paediatric bowel is rarely collected, so we used full-thickness biopsies of the normal ganglionic region of colon from 1 child with HSCR (4 years), the same age as the MEN2B child, and sigmoid colon from 1 child (12 years) with familial adenomatous polyposis (FAP).

In the MEN2B colon, TUJ1-immunoreactivity (TUJ1-IR) showed overgrowth of enteric nerves in all layers (Figure [1](#F1){ref-type="fig"}). Myenteric ganglia were very large, with diameters equal to the thickness of the circular muscle layer (Figure [2A](#F2){ref-type="fig"}). The diameter of the myenteric ganglia was 5-fold more than control (*P* \< 0.0001). The longitudinal muscle layer was significantly thicker than control (*P* \< 0.01), while the circular muscle thickness was less than in controls (*P* \< 0.05). Nerve fibres (Tuj1) in circular muscle were increased so they comprised 25% of the muscle area, compared with 10% in controls (Figure [2A](#F2){ref-type="fig"}). The submucosal ganglia were enlarged and there was a great increase in nerve fibres in the lamina propria (Figure [1B](#F1){ref-type="fig"}). The thickness of muscle layers and size of ganglia in the 2 "controls" were not statistically different, so we combined the results in the quantitation of different neuron types.

![Thickness of muscle layers and ganglia and density of nerve fibres in normal colon and MEN2B colon. A: Comparison of thickness (mm) of muscle and myenteric ganglia in colon from Control (HSCR and FAP) and MEN2B patient. Graph shows mean and SEM. HSCR *n* = 6, FAP *n* = 12, MEN2B *n* = 24, ^a^*P* \< 0.05, ^c^*P* \< 0.001; B: Nerve fibre and ICC density in circular muscle in transverse colon from Control (HSCR and FAP combined, *n* = 3) and MEN2B patient (*n* = 3). Percent area of circular muscle containing immunoreactive pixels; C: Relative nerve fibre and ICC density in the circular muscle in MEN2B patient (*n* = 3) relative to Control patients (HSCR and FAP combined, *n* = 3). Labelling with Tuj1, NOS, VIP, SP and cKit (for interstitial cells of Cajal).](WJGP-8-142-g002){#F2}

Hu-immunoreactivity (IR) shows neuronal cell bodies (Figure [3](#F3){ref-type="fig"}). In myenteric ganglia, there was an increase from 20 to 76 neurons per high power field. As the size of the ganglia increased, nerve fibres also increased greatly and the density of neurons (neurons/mm^2^ of ganglion area) decreased from 1.5/mm^2^ to 0.2/mm^2^. In the submucosa ganglia, neurons increased from 2-3 to 5-10 per ganglia (per high power field) with a great increase in nerve fibres (Figure [3](#F3){ref-type="fig"}).

![Nerve cells in myenteric and submucosal ganglia in normal colon and MEN2B colon. A: Hu immunoreactivity showing nerve cell bodies in transverse colon cut with circular muscle in cross section. Control patient (HSCR) showing myenteric ganglia (MG) neurons and submucosal ganglia; B: MEN2B patient at same magnification showing greatly enlarged MG containing 41 neurons and multiple large ganglia in the submucosa (SMG) containing 2-6 neurons. Note most of the increase in size of the MG is due to nerve fibres; C: Choline acetyle transferase (ChAT) immunoreactivity in transverse colon of MEN2B patient. Note many large ganglia in the submucosa (SM); D: Calcitonin gene-related peptide (CGRP) immunoreactivity in transverse colon of MEN2B patient. CGRP labels extrinsic sensory nerves. Note most of labelling is in the myenteric ganglia; E: ICC in the muscle in normal colon (HSCR); F: MEN2B colon. cKit-immunoreactivity shows ICC in the muscle and around the MG (arrows) and shows mast cells in the mucosa and submucosa. Mast cells are round cells with no process while ICC are elongate cells with processes. ICC numbers are similar in control and MEN2B. The longitudinal muscle (LM), myenteric ganglia (MG), circular muscle (CM), submucosa (SM), submucosal ganglia (SMG) and mucosa (Muc) are shown from left to right.](WJGP-8-142-g003){#F3}

In control and MEN2B, NOS-IR was present in neurons in myenteric ganglia with nerve fibres abundant in the muscle (Figure [4](#F4){ref-type="fig"}), with no labelling in mucosa. NOS nerve fibre density increased 2 fold in the circular muscle (Figure [2](#F2){ref-type="fig"}). VIP-IR nerve fibres increased in the ganglia (Figure [4E](#F4){ref-type="fig"}), and mucosa (Figure [5](#F5){ref-type="fig"}) but proportionally did not change in density in the muscle (Figure [2](#F2){ref-type="fig"}). The increased density of NOS fibres in MEN2B accounted for the significant increase in density of all nerve fibres (Figure [2B](#F2){ref-type="fig"}).

![NOS, VIP and SP nerve fibres in myenteric and submucosal ganglia and circular muscle in normal colon and MEN2B colon. A: NOS-; B: VIP-; C: SP-immunoreactivity in Control (HSCR) patient; D: NOS-; E: VIP-; F: SP-immunoreactivity in MEN2B patient. Note all images are at the same magnification. The enlarged myenteric ganglia (MG) contain many NOS, VIP and SP nerve fibres with NOS at the highest density. The submucosal (SM) ganglia also contain all 3 labels, but SP is most intense and extremely bright in MEN2B. In the circular muscle (CM), NOS is the most abundant and highly increased in MEN2B. Full thickness biopsy of the transverse colon cut with circular muscle in cross section.](WJGP-8-142-g004){#F4}

![VIP and SP nerve fibres in the mucosa in normal colon and MEN2B colon. VIP-immunoreactivity in (A) Control (HSCR) and (B) MEN2B patient. Crypts in transverse colon. VIP immunoreactive nerve fibres (arrows) are plentiful at the base and within the arms of the crypts in the control. There is a large increase in the numbers of VIP-IR nerve fibres and brightness of labelling in the crypts. SP-immunoreactivity in (C) Control (HSCR) and (D) MEN2B patient. Background labelling is higher with SP with labelling of epithelial cells. Varicose nerve fibres are visible (arrows) in a similar pattern to VIP. The thickness and brightness of the nerve fibres is greatly increased within the crypts and in the submucosa in MEN2B. Note all images are at the same magnification.](WJGP-8-142-g005){#F5}

In the MEN2B bowel, SP-IR showed increased nerve fibres in myenteric and submucosal ganglia (Figure [4](#F4){ref-type="fig"}) and in the mucosa (Figure [5](#F5){ref-type="fig"}). The relative amount of SP-IR fibres supplying the circular muscle was greater than in normal colon (Figure [2C](#F2){ref-type="fig"}).

ChAT-IR was high in nerve fibres in the enlarged myenteric and submucosal ganglia with relatively little labelling in the circular muscle or mucosa (Figure [3C](#F3){ref-type="fig"}). CGRP-IR was also high in the myenteric ganglia but low in the muscle, submucosa and mucosa (Figure [3D](#F3){ref-type="fig"}).

c-Kit-IR labelled a relatively normal number of ICC in the muscle layers and mast cells in the lamina propria (Figure [3E](#F3){ref-type="fig"} and F).

At follow-up at 14 years of age, this child is well. Early recognition and treatment (thyroidectomy and colectomy) have enabled normal growth. In addition to colectomy, he has had neuromas removed from his tongue and has nerves growing across his cornea that are monitored 6 monthly.

DISCUSSION
==========

We established the normal ganglion size and area of nerve fibres in the circular muscle in 2 children (aged 4 and 12 years), then compared the area of ganglia and nerve fibres in a 4-year-old child who presented as an infant with constipation and genetic confirmation of MEN2B. We used a range of antibodies to identify nerve cells, fibres, nerve subgroups, and ICC, and found that in MEN2B ganglioneuromatosis, the overgrowth in myenteric ganglia was both nerve cells and fibres with most subpopulations of enteric nerves involved. There was an increase in nerve cell bodies in the submucosal ganglia, with large bundles of nerve fibres in the submucosa reminiscent of HSCR.

In the aganglionic region of Hirschsprung colon, extrinsic nerve fibres form thick cables in the submucosa and myenteric layer. This is thought to be because the lack of nerve cells provides no sites for the extrinsic nerves to synapse onto. In MEN2B submucosa, the nerve fibres also form large cables but with nerve cells present in many ectopic ganglia\[[@B18],[@B20]\]. The presence of neurons among the enlarged nerve fibres has been reported previously as the diagnostic criterion to distinguish MEN2B from Hirschsprung\'s disease\[[@B18]\].

Myenteric interneurons and excitatory motor and sensory neurons that send processes to the muscle and secretomotor neurons in the submucosal ganglia that send processes to the mucosa are cholinergic\[[@B22],[@B23]\]. There was a high level of ChAT labelling in the myenteric ganglia but not in the muscle. The antibody against ChAT only labels proximal processes (*i.e*., nerve fibres near the cell body)\[[@B28]\] and so does not display the nerves in the muscle or mucosa. Identifying the cholinergic nerve fibres in the muscle and mucosa requires labelling with vesicular acetyl choline (VAChT) or high affinity choline transporter (CHT)\[[@B28]\] and was not done in this study. This should be further investigated in future studies.

Nerve fibres containing the inhibitory neurotransmitters, nitric oxide and VIP, were unevenly distributed, with NOS prominent in the muscle layers and VIP prominent in the lamina propria. NOS is present in inhibitory motor neurons in the ganglia, forming connections within the ganglia and sending process into the muscle layers. More NOS-synthesizing fibres in the myenteric layer would increase the inhibitory pathways within the ganglia and more in the muscle layer might inhibit contraction or lead to relaxation. NOS immunoreactive neurons are normally sparse in the submucosal ganglia and their fibres innervate the inner muscle layer. NOS-immunoreactive nerve fibres are not normally present in the muscosa.

SP levels were especially high in the submucosal ganglia and mucosa. Thus, RET overactivation increased all nerve fibres in the myenteric ganglia, NOS in the circular muscle, and VIP and SP in the submucosal ganglia and mucosa. Previous studies have shown histology of ganglia and staining with neuron specific enolase (NSE)\[[@B12],[@B15],[@B19]\] but only one other study has reported labelling for specific neurotransmitters\[[@B20]\]. Previously, in seromuscular biopsies from 2 other MEN2B patients, we noted a decrease in SP in the circular muscle. This may reflect differences between patients in types of nerves that increase\[[@B20]\].

ICC arise from the mesoderm\[[@B25]\]. In this patient there was normal density of ICC suggesting that they are not influenced by RET. Interestingly, ICC numbers were not decreased in the MEN2B patient despite severe constipation. Reduced numbers of ICC are often associated with bowel dysmotility and chronic constipation\[[@B29],[@B30]\].

Mouse models of the human *RET^MEN2B^* gene have produced thyroid and sympathetic ganglioneuroma phenotypes but to date have not reproduced intestinal gangliomatosis\[[@B31]\]. Thus it is difficult to investigate what the molecular mechanism of the *RET^MEN2B^* affects in the enteric nervous system. We can speculate that the activating mutation in *RET^MEN2B^* overrides an "OFF" switch that is normally induced by synapse formation and normally inhibits neuron proliferation and nerve fibre formation. This results in overproduction of nerve fibres in all layers of the bowel.

Different types of neurons differentiate at different times and environmental cues change over time. Neurturin, a GDNF family member, may play a role in development of cholinergic nerves\[[@B32]\]. There is particular interest in determining the factors that induce NOS expression in neuronal stem cells\[[@B32]\], as optimal conditions for differentiation will be needed for potential neuronal transplantation to treat HSCR. MEN2B shows that too much RET activation is not advantageous.

In this patient, overactivation of RET lead to a large increase in neurons and nerve fibres in the myenteric and submucosal ganglia, muscle and mucosa. This patient had a relative increase in NOS-IR nerve fibres in the circular muscle and of VIP-IR and SP-IR nerve fibres in the submucosal ganglia and mucosa. The *RET* gene test was performed after finding the enlarged ganglia in the rectal biopsies at 4 mo old and was positive resulting in a pre-emptive thyroidectomy at 9 mo. The samples studied were collected at 4 years during a partial colectomy. This study indicates that the neuronal growth continues due to the RET activation, independent of thyroid presence. So although removing the thyroid does prevent the MTC\[[@B4]\], the children require ongoing monitoring and maintenance and are not problem free. The child has 6-monthly screening for thyroid with annual ultrasound, annual review of corneal nerves and bowel function. He last had removal of tongue ganglia in 2015 and was seen 3 recently (May 2017) with no new nodules needing treatment. He is now 14 and doing well.

COMMENTS
========

Case characteristics
--------------------

A 4-year-old boy with chronic intractable constipation since a few weeks after birth, diagnosed with multiple endocrine neoplasia 2B (MEN2B) *via* rectal biopsy to exclude Hirschsprung (HSCR) has partial colectomy.

Clinical diagnosis
------------------

MEN2B with proven *M918T-RET* mutation (activating).

Differential diagnosis
----------------------

Hirschsprung\'s disease was main differential, investigated in rectal biopsy at 4 wk of age, showing enlarged nerve fibres and enlarged ganglia rather than lack of enteric neurons.

Laboratory diagnosis
--------------------

Immunohistochemistry showed a large increase in intrinsic nerve fibres in both myenteric and submucosal ganglia, with a relative increase in NOS-IR nerve fibres in the circular muscle and VIP in the submucosal ganglia. GENE analysis identified *M918T-RET* mutation.

Pathological diagnosis
----------------------

MEN2B caused by *RET* gene mutation.

Treatment
---------

Thryoidectomy at 9 mo to prevent medullary thyroid carcinoma, partial colectomy at 4 years to overcome constipation, removal of gangliomas from the tongue. Continued monitoring of thyroid and corneal nerves.

Related reports
---------------

MEN2B is a rare syndrome caused by an activating mutation in the *RET* gene, which produces medullary thyroid cancer, adrenal phaeochromocytoma enlarged nerve fibres and ganglia, including overgrowth of the enteric nerves.

Term explanation
----------------

Nitric oxide synthase (NOS) is present in inhibitory motor nerves and interneurons in the myenteric and submucosal ganglia; VIP (vasoactive intestinal peptide) is also present in secretomotory nerves in the submucosal ganglia and mucosa.

Experiences and lessons
-----------------------

Detailed immunohistochemistry has enabled us to understand the effects of an activating mutation of the *RET* gene in MEN2B, with the relative increase in inhibitory neurotransmitters (NOS and VIP) likely related to the clinical symptoms of intractable constipation.

Peer-review
-----------

Strengths: Endeavours to characterise morphological and immunohistochemical changes of MEN2B associated intestinal ganglioneuromatosis. Found that M918T-induced RET activation led to a large increase in intrinsic nerve fibres in myenteric and submucosal ganglia, specifically NOS and VIP. There is paucity of data on enteric neuronal content in MEN2B other than that ganglia are enlarged.
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